Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Am J Crit Care ; 16(1): 28-36; discussion 37; quiz 38, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17192524

ABSTRACT

BACKGROUND: Ventilator-associated pneumonia accounts for 47% of infections in patients in intensive care units. Adherence to the best nursing practices recommended in the 2003 guidelines for the prevention of ventilator-associated pneumonia from the Centers for Disease Control and Prevention should reduce the risk of ventilator-associated pneumonia. OBJECTIVE: To evaluate the extent to which nurses working in intensive care units implement best practices when managing adult patients receiving mechanical ventilation. METHODS: Nurses attending education seminars in the United States completed a 29-item questionnaire about the type and frequency of care provided. RESULTS: Twelve hundred nurses completed the questionnaire. Most (82%) reported compliance with hand-washing guidelines, 75% reported wearing gloves, half reported elevating the head of the bed, a third reported performing subglottic suctioning, and half reported having an oral care protocol in their hospital. Nurses in hospitals with an oral care protocol reported better compliance with hand washing and maintaining head-of-bed elevation, were more likely to regularly provide oral care, and were more familiar with rates of ventilator-associated pneumonia and the organisms involved than were nurses working in hospitals without such protocols. CONCLUSIONS: The guidelines for the prevention of ventilator-associated pneumonia from the Centers for Disease Control and Prevention are not consistently or uniformly implemented. Practices of nurses employed in hospitals with oral care protocols are more often congruent with the guidelines than are practices of nurses employed in hospitals without such protocols. Significant reductions in rates of ventilator-associated pneumonia may be achieved by broader implementation of oral care protocols.


Subject(s)
Critical Care/standards , Guideline Adherence/statistics & numerical data , Intensive Care Units/standards , Nursing Staff, Hospital/standards , Pneumonia, Ventilator-Associated/prevention & control , Respiration, Artificial/nursing , Adult , Centers for Disease Control and Prevention, U.S. , Clinical Competence , Critical Care/methods , Cross-Sectional Studies , Education, Nursing, Continuing , Health Care Surveys , Humans , Nursing Staff, Hospital/education , Practice Guidelines as Topic , Respiration, Artificial/adverse effects , Surveys and Questionnaires , United States
2.
Am J Cardiol ; 96(3): 447-9, 2005 Aug 01.
Article in English | MEDLINE | ID: mdl-16054480

ABSTRACT

The parasympathetic nervous system facilitates peripheral arterial vasodilation and is also responsible for a decrease in heart rate immediately after exercise (heart rate recovery [HRR]). The relation among parasympathetic tone measured by HRR after exercise, endothelium-mediated vasodilation, and nitroglycerin-mediated vasodilation (determined with brachial artery ultrasound) was assessed in 25 healthy young men. One-minute HRR was nonsignificantly related to endothelium-mediated vasodilation (r = -0.35, p = 0.08) but was significantly related to nitroglycerin-mediated vasodilation (r = -0.63, p = 0.0008), a finding that persisted after adjustment for heart rate at rest, insulin resistance, lipid variables, and blood pressure. This suggests that parasympathetic tone may be inversely related to the responsiveness of arterial smooth muscle to nitrates in healthy humans.


Subject(s)
Brachial Artery/drug effects , Brachial Artery/physiology , Exercise Test , Heart Rate/drug effects , Heart Rate/physiology , Nitroglycerin/pharmacology , Vasodilator Agents/pharmacology , Adult , Blood Flow Velocity , Brachial Artery/diagnostic imaging , Humans , Male , Ultrasonography, Doppler , Vasodilation/drug effects , Vasodilation/physiology
3.
Cancer ; 103(9): 1850-5, 2005 May 01.
Article in English | MEDLINE | ID: mdl-15786422

ABSTRACT

BACKGROUND: A Phase I/II study was designed to show whether the addition of semisynthetic homoharringtonine (sHHT) would reduce the level of residual disease in patients with Ph-positive chronic myeloid leukemia who appeared to have achieved a suboptimal response to imatinib alone. METHODS: Patients with CML who had achieved >/= 35% Ph-negativity on imatinib were included. All patients had been treated with imatinib at >/= 400 mg/day for at least 2 years and had achieved a plateau in BCR-ABL transcripts defined by measuring BCR-ABL transcripts on at least 4 occasions over a minimum period of 1 year with the latest value not lower than the previous minimum value. Initially sHHT was given subcutaneously at a dose of 1.25 mg/m(2) twice daily for 1 day. Courses were repeated every 28 days. The dosage of sHHT was escalated by adding one day of treatment every two days. Efficacy was assessed by serial monitoring of blood levels of BCR-ABL transcripts. RESULTS: Of 10 evaluable patients, 7 had an appreciable decline in BCR-ABL transcript levels; in 5 cases the reduction was greater than 1 log. Asthenia (n = 10) and cytopenias (n = 3) were prominent side-effects, but the drug was generally well tolerated. Mutations in the P-loop of the BCR-ABL kinase domain were found in 2 of the patients who responded to the addition of sHHT. CONCLUSIONS: The addition of sHHT should be considered for patients on imatinib who fail to obtain low levels of minimal residual disease.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Adult , Aged , Benzamides , Cytogenetic Analysis , Drug Resistance, Neoplasm , Female , Fusion Proteins, bcr-abl/antagonists & inhibitors , Fusion Proteins, bcr-abl/genetics , Harringtonines/administration & dosage , Homoharringtonine , Humans , Imatinib Mesylate , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Male , Middle Aged , Mutation , Neoplasm, Residual/diagnosis , Neoplasm, Residual/drug therapy , Piperazines/administration & dosage , Protein Kinase Inhibitors/adverse effects , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrimidines/administration & dosage
4.
J Clin Endocrinol Metab ; 90(6): 3202-8, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15769980

ABSTRACT

CONTEXT: Glucocorticoids are known to acutely increase blood pressure, suppress inflammation, and precipitate insulin resistance. However, the short-term effects of glucocorticoids on other cardiovascular risk factors remain incompletely characterized. OBJECTIVE: Our objective was to determine the effects of a short course of dexamethasone on multiple cardiovascular biomarkers and to determine whether suppression of morning cortisol in response to low-dose dexamethasone is correlated with cardiovascular risk markers in healthy volunteers. DESIGN: We conducted a randomized, double-blind, placebo-controlled study. SETTING: The study took place in a tertiary care hospital. STUDY SUBJECTS: Twenty-five healthy male volunteers, ages 19-39 yr, participated in the study. INTERVENTION: Subjects received either 3 mg dexamethasone twice daily or placebo for 5 d. Subjects also underwent a low-dose (0.5 mg) overnight dexamethasone suppression test. MEASURES: Parameters examined before and after the 5-d intervention included heart rate, blood pressure, weight, fasting lipid variables, homocysteine, renin, aldosterone, insulin resistance (homeostasis model assessment), high-sensitivity C-reactive protein, B-type natriuretic peptide, flow-mediated and nitroglycerin-mediated brachial artery dilatation, and heart rate recovery after exercise. All measurements were done in the morning hours in the fasting state. RESULTS: Dexamethasone increased systolic blood pressure, weight, B-type natriuretic peptide, and high-density-lipoprotein-cholesterol. Dexamethasone decreased resting heart rate, high-sensitivity C-reactive protein, and aldosterone and tended to attenuate nitroglycerin-mediated vasodilatation. There was no effect on flow-mediated vasodilatation, diastolic blood pressure, triglycerides, low-density-lipoprotein-cholesterol, nonesterified fatty acids, homocysteine, or heart rate recovery. The response of circulating cortisol to low-dose dexamethasone had no significant correlation with any of the cardiovascular risk markers. CONCLUSIONS: Short-term glucocorticoids elicits both favorable and unfavorable effects on different cardiovascular risk factors. Manipulation of specific glucocorticoid-responsive physiological pathways deserves further study.


Subject(s)
Biomarkers/blood , Cardiovascular System/drug effects , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Adult , Blood Pressure/drug effects , Body Weight , Brachial Artery/drug effects , Brachial Artery/physiology , Double-Blind Method , Heart Rate/drug effects , Humans , Lipids/blood , Lipoproteins/blood , Lipoproteins/drug effects , Male , Placebos
5.
Nurs Times ; 100(31): 40-3, 2004.
Article in English | MEDLINE | ID: mdl-15360081

ABSTRACT

Nurses play an essential role in preparing patients for surgical procedures, whether the operation is planned or an emergency. Part of this preparation may include administration of premedication. Government initiatives such as The NHS Plan (Department of Health, 2000) and Essence of Care (DoH, 2001) emphasise the need to get the fundamental aspects of nursing care right, and nurses have a professional responsibility to deliver evidence-based care (NMC, 2002). Additionally, the publication of Building a Safer NHS for Patients: Improving Medication Safety (DoH, 2004) aims to improve patient safety by reducing the incidence of drug errors. This article looks at why pharmacological intervention is no longer a routine preoperative preparation. It will discuss drugs that are used to aid anaesthesia and those used as prophylaxis to aid postoperative recovery, consider the ways in which premedication can now include psychological interventions, and look at the nurse's role.


Subject(s)
Preanesthetic Medication , Premedication , Anxiety/prevention & control , Humans , Medication Errors/nursing , Medication Errors/prevention & control , Nurse's Role , Pain, Postoperative/prevention & control , Patient Rights , Perioperative Nursing/methods , Perioperative Nursing/standards , Postoperative Nausea and Vomiting/prevention & control , Preanesthetic Medication/methods , Preanesthetic Medication/nursing , Preanesthetic Medication/standards , Premedication/methods , Premedication/nursing , Premedication/standards , Surgical Wound Infection/prevention & control
6.
Chin Med J (Engl) ; 117(7): 968-71, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15265366

ABSTRACT

BACKGROUND: This study was designed to quantitatively measure WT-1 expression levels in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) during follow-up and to clarify the value of WT-1 as a molecular marker in minimal residual disease monitoring. METHODS: The TaqMan quantitative real-time RT-PCR method was established by using cloned WT-1 cDNA or synthesized oligonucleotides resembling WT-1 cDNA fragments in limit dilution as template until a stable and reliable standard curve was obtained. In a 25-month follow-up, the transcriptional levels of WT-1, Bcr-Abl, and Abl gene, were quantitatively measured in bone marrow cells from 25 CML or acute lymphoblastic leukemia (ALL) patients with the Ph chromosome. In addition, the expression of these genes in 40 samples of normal peripheral blood was also examined using the same method. The ratios of WT-1/Abl and Bcr-Abl/Abl were both plotted, and the two expression patterns were compared as well as their clinical significance. RESULTS: The levels of WT-1 expression in normal peripheral blood were detectable. In CML and Ph positive ALL patients, WT-1 expression levels changed in parallel with the Bcr-Abl expression pattern as the disease progressed or responded to effective treatment. CONCLUSION: WT-1 expression provides a novel molecular marker in addition to Bcr-Abl for monitoring minimal residual disease (MRD) and targeting therapy in Ph chromosome-positive leukemia patients.


Subject(s)
Genes, Wilms Tumor , Genes, abl , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Philadelphia Chromosome , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm, Residual
7.
Nurs Times ; 100(14): 42-4, 2004.
Article in English | MEDLINE | ID: mdl-15119134

ABSTRACT

Excellent communication skills, both verbal and nonverbal, are needed throughout the perioperative experience to educate patients undergoing surgery and so ease their anxiety. In addition, good communication with theatre colleagues, the multidisciplinary team, and other departments is vital to achieve technical excellence and individualised, holistic patient care. This article discusses the importance of effective communication and describes how it can be improved in the perioperative setting.


Subject(s)
Clinical Competence , Communication , Interprofessional Relations , Nurse-Patient Relations , Perioperative Nursing/methods , Humans , Informed Consent , Nurse's Role , Patient Care Team/organization & administration , Patient Education as Topic/methods , Practice Guidelines as Topic , Stress, Psychological/prevention & control , United Kingdom
8.
Nurs Times ; 100(11): 32-5, 2004.
Article in English | MEDLINE | ID: mdl-15060966

ABSTRACT

It is essential for nurses to be aware of their legal and professional obligations regarding health and safety issues in the operating theatre. There should be strict policies and procedures in place to ensure a safe environment and to maintain the sterile field for the benefit of patients, staff and visitors.


Subject(s)
Occupational Health , Operating Room Nursing/methods , Operating Rooms , Safety Management/methods , Humans , Infection Control/methods , Interior Design and Furnishings , Medical Waste Disposal/methods , Nurse's Role , Occupational Exposure/prevention & control , Operating Rooms/organization & administration , Patient Advocacy , Protective Clothing
SELECTION OF CITATIONS
SEARCH DETAIL
...